Avacta Group plc is a life sciences company with a focus on improving healthcare and well-being through innovative oncology drugs and diagnostics. The company operates through two divisions, Diagnostics and Therapeutics. The Therapeutics Division is developing a pipeline of novel Affimer® immunotherapies and pre|CISION™ tumour targeted chemotherapies to address challenges in cancer treatment. The Diagnostics Division supplies in-vitro diagnostic solutions, growing rapidly through an M&A strategy to become a global scale IVD business offering market-leading healthcare solutions. The company's research and development center uses the proprietary Affimer® platform to differentiate immunodiagnostic products, enhancing their performance.
...